Actym Therapeutics has filed a notice of an exempt offering of securities to raise $59,500,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Actym Therapeutics is raising $59,500,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Christopher Thanos played a key role…
